Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDAH1 | O94760 | 1/20 | 0.61 |
| ▸ | AOC2 | O75106 | 1/20 | 0.56 |
| ▸ | MGLL | Q99685 | 9/20 | 0.56 |
| ▸ | FAAH | O00519 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.54 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.54 |
| ▸ | MPO | P05164 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KDM5A | P29375 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | GFER | P55789 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17969213 | 0.98 | DDAH1 (0.59) | DDAH1AOC2MGLLFAAHKDM4E | |
| Trifluoroacetic Acid SCHEMBL20945171 | 0.89 | DDAH1 (0.54) | DDAH1AOC2MGLLFAAHKDM4E | |
| SCHEMBL10968265 | 0.83 | DDAH1 (0.63) | DDAH1MGLLFAAHHSP90AA1NPSR1 | |
| SCHEMBL17235983 | 0.82 | CYP1A2 (0.57) | DDAH1MGLLFAAHKDM4EHSP90AA1 | |
| SCHEMBL14000501 | 0.81 | DDAH1 (0.61) | DDAH1MGLLFAAHHSP90AA1NPSR1 | |
| SCHEMBL10973003 | 0.81 | DDAH1 (0.56) | DDAH1MGLLFAAHHSP90AA1NPSR1 | |
| SCHEMBL17231644 | 0.81 | HPGD (0.58) | DDAH1MGLLFAAHHSP90AA1NPSR1 | |
| SCHEMBL22520781 | 0.81 | DDAH1 (0.56) | DDAH1MGLLFAAHHSP90AA1NPSR1 | |
| SCHEMBL8404261 | 0.80 | DDAH1 (0.59) | DDAH1MGLLFAAHKDM4EHSP90AA1 | |
| SCHEMBL12268629 | 0.80 | DDAH1 (0.59) | DDAH1MGLLFAAHKDM4EHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210002222-A1 | AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS | 3R VALO, S.E.C. (CA) | 2021-01-07 | — | — | US | disclosed |
| EP-3442943-B1 | AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS | 3R VALO S E C (CA) | 2020-10-07 | — | — | EP | disclosed |
| US-10759754-B2 | Aminobenzoic acid derivatives for use as anti-inflammatory agents, anti-metastatic agents and/or anticancer agents | 3R VALO, S.E.C. (CA) | 2020-09-01 | — | — | US | disclosed |
| US-20190127325-A1 | AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS | UNIVERSITÉ DU QUÉBEC À TROIS-RIVIÈRES (CA) | 2019-05-02 | — | — | US | disclosed |
| WO-2017177316-A1 | AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS | 3R VALO, S.E.C. (CA) | 2017-10-19 | — | — | WO | disclosed |
| EP-2152312-B1 | LOW-VISCOUS ANTHRACYCLINE FORMULATION | KTB TUMORFORSCHUNGS GMBH (DE) | 2014-12-31 | — | — | EP | disclosed |
| US-8703724-B2 | Low-viscous anthracycline formulation | KTB TUMORFORSCHUNGS GMBH (DE) | 2014-04-22 | — | — | US | disclosed |
| US-20100152273-A1 | LOW-VISCOUS ANTHRACYCLINE FORMULATION | KTB TUMORFORSCHUNGSGESELLSCHAFT MBH (DE) | 2010-06-17 | — | — | US | disclosed |
| EP-2152312-A1 | LOW-VISCOUS ANTHRACYCLINE FORMULATION | KTB Tumorforschungsgesellschaft mbH (DE) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008138646-A1 | LOW-VISCOUS ANTHRACYCLINE FORMULATION | KTB TUMORFORSCHUNGSGESELLSCHAFT MBH (DE) | 2008-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210002222-A1 | AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS | NFKBIA, NFKB1, NFRKB | DDAH1 1457/4885AOC2 2224/4885MGLL 4510/4885 |
| US-20190127325-A1 | AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS | NFKBIA, NFKB1, NFRKB | DDAH1 1457/4885AOC2 2224/4885MGLL 4510/4885 |
| US-10759754-B2 | Aminobenzoic acid derivatives for use as anti-inflammatory agents, anti-metastatic agents and/or anticancer agents | NFKBIA, NFKB1, NFRKB | DDAH1 1457/4885AOC2 2224/4885MGLL 4510/4885 |
| US-20100152273-A1 | LOW-VISCOUS ANTHRACYCLINE FORMULATION | TOP2A, TOP1, TOP2B | DDAH1 4334/4885AOC2 3898/4885MGLL 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.